Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4068 results

Sort By:

Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function

Study ID: NCT05048368
Start Date: 2026-10-30
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

32

Intervention / Treatment

Larried

Sponsor

Sunshine Lake Pharma Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

No Time to Pause: Physical Activity to Improve Health of Midlife Hispanic Women

Study ID: NCT06376812
Start Date: 2026-05
End Date: 2029-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Physical activity intervention

Sponsor

The University of Texas Medical Branch, Galveston

Source: clinicaltrials.gov

Share:
Add to list

Rct Deep Margin Elevation by Self Adhesive Composite

Study ID: NCT06899412
Start Date: 2025-08-01
End Date: 2026-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

self adhesive flowable composite

Conventional flowable composite

Sponsor

Cairo University

Source: clinicaltrials.gov

Share:
Add to list

Role of Estrogen on Skeletal Outcomes in FHA

Study ID: NCT07010146
Start Date: 2025-07-01
End Date: 2030-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

150

Intervention / Treatment

transdermal 17β-E2 with cyclic progestin

oral 17β-E2 with cyclic progestin

Transdermal EE+LNG

Sponsor

University of Virginia

Source: clinicaltrials.gov

Share:
Add to list

Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma

Study ID: NCT06846346
Start Date: 2025-09
End Date: 2028-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

88

Intervention / Treatment

Ivonescimab

FOLFOX regimen

Irinotecan

Paclitaxel

Sponsor

UNICANCER

Source: clinicaltrials.gov

Share:
Add to list

Effect of STRAIN COUNTER-STRAIN ON PATIENTS WITH ANKLE SPRAINS

Study ID: NCT06954012
Start Date: 2025-08-01
End Date: 2026-03-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

36

Intervention / Treatment

EXERCISE TRAINING WITH OR WITHOUT MEDICATION

Exercise

Sponsor

Al-ahliyya amman university

Source: clinicaltrials.gov

Share:
Add to list

Improving Coping to Reduce Suicide Risk Following ED Discharge

Study ID: NCT06614946
Start Date: 2025-08
End Date: 2026-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Electronic Safety Plan (ESP)

Text support

Sponsor

University of Michigan

Source: clinicaltrials.gov

Share:
Add to list

Sufentanil Versus Ketamine Intranasally in the Management of Severe Acute Trauma-related Pain in Children.

Study ID: NCT06968546
Start Date: 2025-09-01
End Date: 2028-03-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

100

Intervention / Treatment

Intranasal Sufentanil

Intranasal Ketamine (IN)

Sponsor

Fondation Lenval

Source: clinicaltrials.gov

Share:
Add to list

Aerodynamic Measurements in the Pediatric Population

Study ID: NCT06975046
Start Date: 2025-07
End Date: 2030-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

365

Intervention / Treatment

Complete airflow interruption

Incomplete airflow interruption

Airflow redirection

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

Comparison of Efficacy Between ILM Forceps

Study ID: NCT06536569
Start Date: 2025-07-01
End Date: 2026-01-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

56

Intervention / Treatment

Internal limiting membrane (ILM) Peeling with Sharkskin Forceps

Internal limiting membrane (ILM) Peeling with Standard Forceps

Sponsor

University of British Columbia

Source: clinicaltrials.gov

Share:
Add to list